Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
Advanced Drug Delivery Reviews · 2023-11 · 202 · 115111
DOI: 10.1016/j.addr.2023.115111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-11. Verfasst von Zhaokui Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, PR China. Hauptthemen laut MEDLINE: Nanoparticles, Lung Diseases. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 213 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, PR China.
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, PR China. Electronic address: tjuguoweisheng@126.com.
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, PR China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National C…
Zitieren
APA
Jin, Z., Gao, Q., Wu, K., Ouyang, J., Guo, W., & Liang, X. J. (2023). Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Advanced Drug Delivery Reviews, 202, 115111. https://doi.org/10.1016/j.addr.2023.115111
Vancouver
Jin Z, Gao Q, Wu K, Ouyang J, Guo W, Liang XJ. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Advanced Drug Delivery Reviews. 2023;202:115111. doi:10.1016/j.addr.2023.115111
BibTeX
@article{Jin2023,
author = {Jin, Zhaokui and Gao, Qi and Wu, Keke and Ouyang, Jiang and Guo, Weisheng and Liang, Xing-Jie},
title = {Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
volume = {202},
pages = {115111},
doi = {10.1016/j.addr.2023.115111}
}
EUVIMED